Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome

OBJECTIVES: To evaluate whether three daily doses of GnRH agonist (Inj. Lupride 1 mg SC) administered 6 days after oocyte retrieval increases ongoing pregnancy rates following embryo transfer (ET) in cycles stimulated with the long GnRH agonist protocol. SETTINGS AND DESIGN: Prospective randomized c...

Descripción completa

Detalles Bibliográficos
Autores principales: Inamdar, Dattaprasad B, Majumdar, Abha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604836/
https://www.ncbi.nlm.nih.gov/pubmed/23532169
http://dx.doi.org/10.4103/0974-1208.106341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604836/
https://www.ncbi.nlm.nih.gov/pubmed/23532169
http://dx.doi.org/10.4103/0974-1208.106341

Ejemplares similares